Drugs of abuse tests using hair samples outside FDA's scope, Psychemedics argues.
This article was originally published in The Tan Sheet
Executive Summary
DRUGS OF ABUSE HAIR TESTS FALL OUTSIDE FDA PURVIEW, PSYCHEMEDICS argues, because the components of the test systems are not intended to diagnose or treat a disease or condition, the company maintains in a July 6 letter to FDA. "FDA lacks jurisdiction to regulate test systems that detect drugs of abuse in hair because they are not medical devices within the meaning" of the FD&C Act, the Culver City, Calif.-based marketer of the OTC PDT-90 Personal Drug Testing Service asserts.You may also be interested in...
People In Brief
Perrigo promotes in pricing, planning
In Brief
Combe sells most of its OTC brands
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: